Head-to-head · Cost-Efficiency Index
Fierce Health vs Joey Med
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Fierce Health
Shoppers specifically seeking a below-standard 'microdose' GLP-1 protocol at a discounted entry price.
Visit Fierce HealthJoey Med
Shoppers who want to pick a molecule-agnostic 'Core / Plus Core' tier and pay per 4, 8, or 12 weeks rather than a recurring monthly subscription.
Visit Joey MedThe verdict
Fierce Health takes it, leading the Cost-Efficiency Index 55 to 54. Fierce Health is a Shopify-storefront telehealth/e-commerce hybrid selling 'microdose' compounded semaglutide (From $197, discounted from a stated $591 regular price) and tirzepatide (From $297, not discounted). Joey Med still earns a C — Shoppers who want to pick a molecule-agnostic 'Core / Plus Core' tier and pay per 4, 8, or 12 weeks rather than a recurring monthly subscription.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Fierce Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Fierce Health | Joey Med |
|---|---|---|
| Cost-Efficiency Index | 55/100 | 54/100 |
| Semaglutide / mo | Not disclosed | $199/mo (promotional rate, compounded) |
| Tirzepatide / mo | Not disclosed | $275/mo (promotional rate, compounded) |
| Semaglutide / yr (modeled) | — | $2,388 |
| Tirzepatide / yr (modeled) | — | $3,300 |
| Coverage | 30 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #351 | #356 |
Fierce Health
55/100Where the value is
- Semaglutide is currently listed at a steep markdown ($197 vs. a stated $591 regular price) if the discount holds at checkout
- Sells both semaglutide and tirzepatide with clearly separated pricing rather than bundling them
- Discloses the standard compounding/FDA disclaimer plainly in the footer
The tradeoffs
- The $591 'regular price' next to a $197 'sale price' is a large, unexplained gap — no page discloses how long the discount lasts or what the price reverts to
- No mg dose amount is disclosed for either 'microdose' product on any page reached
Joey Med
54/100Where the value is
- The site's own embedded pricing data is fully itemized by tier (4/8/12 weeks) for all three products
- Molecule names are disclosed on the category page even though individual product pages use branded tier names
- Legal entity is disclosed via the site's own structured data: MD Telehealth Platform LLC DBA Joey Med
The tradeoffs
- The current roster's prices were stale: $279 was the crossed-out list price for semaglutide (actual: $199), and $399 belonged to the High Dose tirzepatide tier, not the standard $275 entry tier
- Drug names are buried under branded tier names on the product pages themselves
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.